Copyright
©The Author(s) 2015.
World J Respirol. Jul 28, 2015; 5(2): 160-165
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.160
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.160
Institution, country | Number of participants | Number (%) of positive results | Number (%) of diagnosed lung cancer | NSCLC | Stage I disease | Mean age of participants |
Early Lung Cancer Action Project (ELCAP), United States[10,14] | 1000 | 233 (23) | 27 (2.7) | 96% | 85% | 67 |
New York Early Lung Cancer Action Project (NY-ELCAP), United States[15] | 6295 | 906 (14) | 101 (1.6) | 94% | 97% | 66 |
International Early Lung Cancer Action Project (I-ELCAP), United States[3] | 31567 | 4186 (13) | 405 (1.3) | - | 86% | 61 |
Mayo Clinic, United States[9,16,17] | 1520 | 782 (51) | 30 (2) | 93% | 75% | 59 |
Anti-Lung Cancer Association (ALCA), Japan[18] | 1611 | 186 (11.5) | 13 (0.9) | 100% | 77% | 60 |
University of Munster, Germany[19,20] | 817 | 350 (43) | 11 (1.3) | 91% | 70% | 53 |
Pomeranian Pilot Program of Lung Cancer Screening, Poland[21] | 2002 | 982 (49) | 11 (0.5) | 100% | 91% | 59 |
Total | 44812 | 7625 (17) | 598 (1.3) | |||
Median | 6402 | 1089 (17) | 85 (1.3) |
- Citation: Szczęsny TJ, Kanarkiewicz M, Kowalewski J. Screening for lung cancer with chest computerized tomography: Is it cost efficient? World J Respirol 2015; 5(2): 160-165
- URL: https://www.wjgnet.com/2218-6255/full/v5/i2/160.htm
- DOI: https://dx.doi.org/10.5320/wjr.v5.i2.160